A second-generation Smoothened (Smo) antagonist has shown excellent efficacy in rodent tumor models
Author Archive for: Scott Williams (55)
Discovery of Unexpectedly Active Group
Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off
Red Light for Breast Cancer Metastasis
Sipholenol analogues revealed as novel scaffolds for drugs that inhibit breast cancer cell migration and invasion
A Full Stack with Protein Amides
Investigation of π-stacking interactions of protein amides could improve rational drug design
Opening Doors in TB Drug Discovery
Open-source compound library at GSK identifies 177 small-molecule leads for anti-tuberculois (TB) research
New Inhibitors for West Nile Virus
Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease
Tin(IV)-based Anticancer Drugs
Butyltin(IV) benzoates show inhibition of thioredoxin reductase, interactions with proteins, and tumor cell growth inhibition
Keeping Heart Disease at BAY
Structure–activity relationships of non-steroidal antagonist series identifies BAY 94-8862 as a potential treatment for chronic heart failure
Bugs Can't Get a Firm Grip on UTIs
Series of biphenyl α-D-mannosides could prevent and treat urinary tract infections (UTIs) by blocking bacterial adhesion to host cells
Hitting Malaria Where It Hurts
Miniaturized high-throughput screening assays could help identify a prophylactic strategy against liver-stage malaria